7th International Meeting on Lung Cancer

67
Speakers
2
Days
167
Registrations
20
Sponsors

Chairs G. Antoniou (UK), D. Papadatos-Pastos (UK)
08.50-09.10 The treatment of ALK / ROS1 NSCLC: An update P. Christopoulos (DE)
09.10-09.30 EGFR mutant NSCLC: Identifying the optimal first-line treatment E. Vorrias (CY)
09.30-09.50 MET, HER2, RET and NTRK alterations or RET resistance Th. Tegos (GR)
09.50-10.10 KRAS-mutant NSCLC beyond G12C O. Fiste (GR)
10.10-10.20 Discussion

Chairs: E. Vorrias (CY), F. Koinis (GR)
What Comes After Immunotherapy? Strategies Beyond Progression in Metastatic NSCLC G. Tsakonas (CY)

Chairs: D. Papadatos-Pastos (UK), G. Imseeh (UK), N. Panagiotopoulos (UK)
11.20-11.40 Redefining Cure in NSCLC: Where Are We in 2026? / From Surgery
to Systemic Therapy: The New Curative Continuum in NSCLC G. Evangelou (GR)
11.40-12.00 Radiotherapy in the Curative Setting: From Stand-Alone to Strategic Partner / When Surgery Is Not the Answer: Alternative Curative Strategies K. Ferentinos (CY)
12.00-12.20 Case 1 - Neoadjuvant treatment IIIA D. Ragias (GR)
12.20-12.40 Case 2 - Borderline / perioperative resectable V. Aidarinis (GR)
12.40-13.00 Case 3 - Unresectable patient, Stage III A.M. Shiarli (CY)
13.00-13.20 Tumor Board: N. Konstantinidis (GR), K. Xydis (GR), E. Vorrias (CY), Ch. Charalambous (CY), G. Maravelis (GR), D. Vassos (GR), D. Papadatos-Pastos (UK)

Chairs: D. Papadatos-Pastos (UK), G. Imseeh (UK)
Long-term survival data in mNSCLC P. Katsaounis (GR)
Sponsored by MSD

Chairs: F. I. Dimitrakopoulos (GR), F. Koinis (GR)
Three Years of the Thoracic Research Network: From Connection
to Consequence F. I. Dimitrakopoulos (GR), F. Koinis (GR)
• Biomarkers
• Translational Research
Panel: A. Kotsakis (GR), K. Ferentinos (CY), E. Vorrias (CY), G. Tsakonas (CY),
N. Panagiotopoulos (UK), G. Antoniou (UK), E. Boleti (UK), Th. Tegos (GR),
Ch. Charalambous (CY), A.M. Shiarli (CY), G. Evangelou (GR), G. Kallergi (GR),
N. Asimakopoulou (GR), I. Pateras (GR), D. Papadatos-Pastos (UK), A. Koulouris (SE),
E. Fergadis (GR)

Chairs: F. Koinis (GR), G. Gomatou (GR)
17.00-17.30 The Evolving Landscape of Daiichi Sankyo’s Pipeline in Lung Cancer D. Krikelis (GR)
17.30-18.00 Johnson & Johnson: Lung Cancer’s Portfolio Innovation Across the Treatment Landscape A. Theodorou (GR)

Chairs: S. Agelaki (GR), F.I. Dimitrakopoulos (GR)
18.00-18.20 Modern Treatment Algorithm of Extensive-Stage SCLC I. Mountzios (GR)
18.20-18.40 Case 1 - Experience from Tarlatamab S. Arora (UK)
18.40-19.00 Case 2 - Experience from Lurbinectedin Ch. Charalambous (CY)
19.00-19.20 Case 3 - Mesothelioma M. Pandi (GR)
Panel Discussants: F. Koinis (GR), N. Panagiotopoulos (UK), G. Gomatou (GR), Ch. Charalambous (CY)

Chairs: A. Kotsakis (GR), F.I. Dimitrakopoulos (GR)
Cellular Therapies in Lung Cancer: From Biological Promise to Clinical Reality G. Fotopoulos (US)

Chairs: Ch. Charalambous (CY), V. Georgoulias (GR)
08.30-08.50 Targeted Therapies against EGFR in Early NSCLC:
Recent Advances E. Fergadis (GR)
08.50-09.10 Targeting ALK in Early-Stage NSCLC N. Asimakopoulou (GR)
09.10-09.30 Beyond EGFR and ALK in Early-Stage NSCLC A. Boukouris (GR)
09.30-09.50 Case 1 - EGFR mutant E. Koustas (GR)
09.50-10.10 Case 2 - EGFR-mutated NSCLC with disease progression on first-line therapy M. Papadakis (GR)
Tumor Board: P. Christopoulos (DE), F. Koinis (GR), D. Papadatos-Pastos (UK)

Chairs: P. Constantoulakis (GR), G. Tsakonas (CY)
10.40-11.05 ctDNA in early-stage disease F. Koinis (GR)
11.05-11.30 Plasma-first strategies: Blood-based Biomarkers useful in NSCLC management E. Papadopoulou (GR)
Panel Discussants: A. Kotsakis (GR), D. Papadatos-Pastos (UK), Ch. Charalambous (CY)

Chairs: A. Koutsopoulos (GR), P. Constantoulakis (GR)
11.40-12.00 Synthetic lethality and epigenetics A. Klinakis (GR)
12.00-12.20 Tumor microenvironment in NSCLC and molecular landscape I. Pateras (GR)
12.20-12.40 Who Really Benefits from Immunotherapy? Biomarkers Beyond PD-L1 in Metastatic NSCLC A. Koulouris (SE)
12.40-13.00 Discussion

Chairs: P. Christopoulos (DE), I. Pateras (GR)
Advancing Lung Cancer Staging - IASLC Recommendations and Bioinformatics M. Allgäuer (DE)

Chairs: F. Koinis (GR), F.I. Dimitrakopoulos (GR)
• Real World Data & Registries
• Clinical Trials
Panel: A. Kotsakis (GR), K. Ferentinos (CY), E. Vorrias (CY), G. Tsakonas (CY), N. Panagiotopoulos (UK), G. Antoniou (UK), E. Boleti (UK), Th. Tegos (GR), Ch. Charalambous (CY), A.M. Shiarli (CY), G. Evangelou (GR), G. Kallergi (GR), N. Asimakopoulou (GR), I. Pateras (GR), D. Papadatos-Pastos (UK), A. Koulouris (SE), E. Fergadis (GR)

Chairs: G. Stratakos (GR), G. Maravelis (GR)
16.00-16.20 Current Status and Future Perspectives of Interventional Pulmonology in Lung Cancer F. Sampsonas (GR)
16.20-16.40 Creating Opportunity: How Interventional Pulmonology Shapes Treatment Pathways N. Panagiotopoulos (UK)
16.40-17.00 Stereotactic Radiotherapy: Timing, Biology and Integration with Systemic Therapy A.M. Shiarli (CY)
17.00-17.10 Case Discussion V. Adamou (CY)

Chairs: S. Agelaki (GR), P. Savvides (US)
17.30-17.50 Key ADC targets: TROP2, HER3, B7-H3 and Beyond E. Boleti (UK)
17.50-18.10 Resistance to ADCs and Rational Combinations: What Comes Next? G. Evangelou (GR)
18.10-18.30 Case 1 - Enhertu in HER2-Mutant NSCLC K. Baines (UK)
18.30-18.50 Case 2 - Datopotamab P. Savvides (US)
18.50-19.00 Tumor Board: F. Koinis (GR), D. Papadatos-Pastos (UK), Th. Tegos (GR), E. Vorrias (CY)

Chairs: C. Baxevanis (GR), O. Tsitsilonis (GR)
19.00-19.25 Beyond KRAS G12C F. Skoulidis (US)
19.25-19.50 Cancer Vaccines in Lung Cancer: Are We Finally Ready? V. Karantza (US)
19.50-20.00 Discussion

Adamou V.
Medical Oncology Resident, Bank of Cyprus Oncology Centre, Cyprus
Agelaki S.
Associate Professor in Medical Oncology, University of Crete, Greece
Aidarinis V.
Resident of Medical Oncology University Hospital of Larissa
Allgäuer M.
PhD, Pathologist, Institute of Pathology, Heidelberg University Hospital, Germany
Antoniou G.
MD, MSc, PhD, Consultant Medical Oncologist, Mount Vernon Cancer Centre, UK
Arora S.
Oncology, Resident Medical Officer, The London Clinic, UK
Asimakopoulou N.
MD, PhD, Medical Oncologist, 1st Oncology Dpt, Metropolitan General, Athens, Greece
Baines K.
Specialist Registrar in Medical Oncology, St Bartholomew’s Hospital, Resident Medical Officer in Oncology, The London Clinic, Clinical Research Fellow, Barts CancerInstitute, QueenMary University of London, UK
Baxevanis K.
Scientific Director, Cancer Immunology and Immunotherapy Center “Agios Savvas”, Hospital, Athens, Greece
Boleti K.
MD, PhD, FRCP, Consultant Medical Oncologist, Department of Oncology, Royal Free London NHS Foundation Trust, London, UK
Boukouris A.
MD, PhD, Medical Oncology Resident, University General Hospital of Heraklion, Greece
Charalambous C.
BM, MRCP, FRCR, Consultant Clinical Oncologist, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Christopoulos P.
Professor of Medicine at Heidelberg University, MD, PhD, Hematologist & Medical Oncologist in the Thoraxklinik and National Center for Tumor Diseases, (NCT) at Heidelberg University Hospital, Germany
Constantoulakis P.
PhD, Scientific Director, GENOTYPOS MSA
Dimitrakopoulos F. I.
MD, PhD, Medical Oncologist, Division of Oncology & Molecular Oncology Laboratory, Department of Medicine, University of Patras, Greece
Evangelou G.
MD, MSc, PhD, Medical Oncologist, 3rd Department of Medicine, NKUA, Sotiria Hospital, Athens, Greece
Ferentinos K.
MD, PhD, MHBA, Director, Department of Radiation Oncology, German Oncology Center, Limassol, Cyprus
Fergadis E. G.
Medical Oncologist, Consultant, “Metaxa” Hospital, Piraeus, Greece
Fiste O.
MD, MSc, PhD, Medical Oncologist, 3rd Department of Internal Medicine and the Affiliated Laboratory, School of Medicine, National and Kapodistrian University of Athens, “Sotiria” Hospital, Athens, Greece
Fotopoulos G.
Assistant Professor of Medicine in the Division of Hematology/Oncology at Ut Health San Antonio, USA, Medical Oncology Consultant, BOCOC, Cyprus
Georgoulias V.
Professor Emeritus of Medical Oncology, University of Crete, Heraklion, Greece
Gomatou G.
MD, PhD, Medical Oncologist, 2nd Propaedeutic Department of Internal Medicine, Attikon University Hospital, Greece
Imseeh G.
MRCP FRCR MD(Res), Consultant Clinical Oncologist in Thoracic and Uro-Oncology, Interim Clinical Service Lead for Oncology at North Mid, RCR Joint College Tutor for Clinical Oncology Trainees at North Mid, UCLMS Honorary Clinical Lecturer and Undergraduate Oncology Lead at North Mid, UK
Kallergi G.
Associate Professor of Biochemistry, Department of Biology, University of Patras, Greece
Karantza V.
MD, PhD, Professor of Medicine, Rutgers New Jersey Medical School, USA
Katsaounis P.
MD, MSc, Medical Oncologist, Metropolitan General Hospital, Athens, Greece
Klinakis A.
PhD, Investigator, Biomedical Research Foundation of the Academy of Athens, Greece
Koinis F.
MD, PhD, Assistant Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
Konstantinidis K.
MD, MSc, FEBTS, 251 Hellenic Airforce General Hospital, Henry Dynan Hospital, Athens, Greece
Kotsakis Α.
MD, PhD, Professor of Medical Oncology, Director of Department of Medical Oncology, University Hospital of Larissa, Thessaly, Greece
Koulouris A.
MD, Oncologist, Theme Cancer, Karolinska University Hospital / Department of Oncology - Pathology, Karolinska Institutet, Sweden
Koustas E.
MD, PhD, Resident in Medical Oncology, Oncology Department, ‘‘Evangelismos’’ General Hospital, Athens, Greece
Koutsopoulos A.
MD, PhD, Associate, Professor of Pathology, Department of Pathology, School of Medicine, University of Crete
Krikelis D.
MD, PhD, Medical Oncologist, Head of Medical Affairs, Daiichi Sankyo Greece
Maravelis G.
MD, PhD, Deputy Director, Radiation Oncology Department, “Metropolitan” Hospital, Piraeus, Greece
Mountzios I.
Consultant-Medical Oncologist, 2 nd Oncology Department and Clinical T rials Unit, Henry Dunant Hospital, Oncolife Institute Founder
Panagiotopoulos N.
PhD, FICS, FSSO, Thoracic and Robotic Surgeon, Cleveland Clinic London, UK
Pandi M.
MD, Resident in Medical Oncology, Oncology Department, University Hospital of Patras, Greece
Papadakis V.
MD, PhD, Director NHS, Department of Pediatric Hematology - Oncology
Papadatos-Pastos D.
MRCP(UK), PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals and The Princess Alexandra Hospital, UK
Papadopoulou Eir.
PhD, International Laboratory Director, Genekor Medical S.A., Greece
Pateras I.
Pathologist, Assοciate Professor, 2nd Department of Pathology, “Attikon” University Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Sampsonas F.
Associate Professor of Internal Medicine - Interventional Pulmonology, Department of Medicine, University of Patras, Greece
Savvides P.
MD, PhD, MPH, Senior Associate Consultant, Thoracic H&N Medical Oncology, Mayo Clinic Arizona, USA
Shiarli A.M.
MBChB, BSc (Hons), MRCP (UK), FRCR, Consultant Clinical Oncologist, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Skoulidis F.
MD, PhD, Associate Professor, Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, USA
Stratakos G.
MD, PhD, FCCP, Professor of Respiratory Medicine and Interventional Pulmonology, National and Kapodistrian University of Athens, Head Interventional Pulmonology Unit -1st Respir. Med. Dept, N.K. University of Athens, “Sotiria” Hospital, Athens, Greece. President, European Association for Bronchology and Interventional Pulmonology
Tegos T.
MD, PhD, Medical Oncologist, Evangelismos General Hospital, Athens, Greece
Theodorou A.
Medical Affairs Oncology, Johnson & Johnson, Greece
Tsakonas G.
MD, Senior Consultant, Lung Oncology Center, Theme Cancer Karolinska University Hospital, Associate Professor in Oncology, Department of Oncology and Pathology Karolinska Institutet, Stockholm, Sweden
Tsitsilonis O.
MD, PhD, Professor of Immunology, Department of Biology, NKUA
Vassos D.
MD, MSc, Pulmonologist, Metropolitan General Hospital, Athens, Greece
Vorrias E.
MD, Medical Oncologist, German Medical Institute, Limassol, Cyprus
Xydis K.
MD, MSc, PhD, Radiation Oncologist, Hygeia Hospital, Athens, Greece, Athens Medical Center, IASIS Clinic, Chania, Greece
Αλεξόπουλος Α.
MD, PHD, Παθολόγος - Ογκολόγος, ΔΘΚΑ ΥΓΕΙΑ
Αρδαβάνης Α.
MD, PhD, Διευθυντής - Επιστημονικά Υπεύθυνος Α’ Παθολογικού - Ογκολογικού Τμήματος, Γ.Α.Ο.Ν.Α. «Ο Άγιος Σάββας», Αθήνα

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details
Sponsors